AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2161578
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral + intramuscular estrogens
Trial: 2161578
Drug: Single drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single drug intramuscular estrogens
Trial: 16413878
Drug: Zinc alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc alone (10 mg)
Trial: 11528551
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose cytarabine and mitoxantrone (HAM)
Trial: 19506
Drug: Single graded
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single graded intramuscular doses of morphine test
Trial: 19506
Drug: Single graded
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single graded intramuscular doses of morphine standard
Trial: 19903574
Drug: Quetiapine XR
RxNorm normalized name: quetiapine Extended Release Oral Tablet
DrugBank: Quetiapine (DB01224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quetiapine XR 300 mg once daily
Trial: 21371314
Drug: Prolonged conservative
RxNorm normalized name: Conserved dopamine neurotrophic factor
DrugBank: HER-902 (DB17948)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged conservative treatment (further treatment from general practitioner and physical therapist)
Trial: 16757722
Drug: Clinical pathway
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical pathway treatment
Trial: 14707554
Drug: 546C88 (nitric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 546C88 (nitric oxide synthase inhibitor)
Trial: 11334121
Drug: Patient education
RxNorm normalized name: DIABETES PATIENT EDUCATION PACK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient education intervention consisting of two 2-hour group sessions followed by 1-2 individual sessions administered by a nurse and a physiotherapist, emphasizing self-management
Trial: 9013165
Drug: Prior medical
RxNorm normalized name: Priorix
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prior medical therapy
Trial: 8525817
Drug: Tenoxicam 10
RxNorm normalized name: tenoxicam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenoxicam 10 mg daily for 6 weeks
Trial: 8525817
Drug: Tenoxicam 20
RxNorm normalized name: tenoxicam 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenoxicam 20 mg daily for 6 weeks
Trial: 2691121
Drug: Pirenzepine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirenzepine (200 mg p.o.)
Trial: 30526266
Drug: Corrective exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corrective exercise program based on National Academy of Sport Medicine guidelines
Trial: 31446638
Drug: PEG‐IFN-based therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG‐IFN-based therapy
Trial: 31446638
Drug: Baseline HBV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline HBV RNA (cut-off 2.0 log10 copies/mL)
Trial: 22078152
Drug: Acarbose (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose (50 mg TID for 4 weeks, then 100 mg TID for 12 weeks)
Trial: 22078152
Drug: Glibenclamide (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glibenclamide (2.5 mg TID for 4 weeks, then 5 mg TID for 12 weeks)
Trial: 19909879
Drug: Combined dose
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined dose group of Ambrisentan
Trial: 16510054
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of 0.5 cc lidocaine 1% plus methylprednisolone acetate (Depo-Medrol) 40 mg
Trial: 15131559
Drug: Cardiac rehabilitation
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac rehabilitation and prevention program (CRPP) - 2-hour twice-weekly exercise program for 8 weeks
Trial: 9587651
Drug: Erythromycin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (100 mg or 500 mg intravenously)
Trial: 1320559
Drug: Conventional medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional medical therapy
Trial: 29228247
Drug: ASP8477 (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASP8477 (all doses)
Trial: 27861191
Drug: Levomilnacipran extended-release
RxNorm normalized name: levomilnacipran Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levomilnacipran extended-release (ER) 40-120 mg/day
Trial: 16519552
Drug: 0.03% bimatoprost
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.03% bimatoprost ophthalmic solution once daily
Trial: 23997106
Drug: Melatonin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (3 mg)
Trial: 24812896
Drug: Control (routine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (routine therapy)
Trial: 20124229
Drug: Diclofenac, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac, 50 mg, twice daily for 14 days
Trial: 10510993
Drug: Isolated soy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isolated soy protein with 62 mg of isoflavones
Trial: 10510993
Drug: Isolated soy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isolated soy protein with 37 mg of isoflavones
Trial: 10510993
Drug: Ethanol-extracted isolated
RxNorm normalized name: Serenoa Repens Fruit Ethanol Extract
DrugBank: Saw palmetto (DB14360)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol-extracted isolated soy protein containing 3 mg of isoflavones
Trial: 8748255
Drug: IL-10 (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-10 (single intravenous injection)
Trial: 1889712
Drug: Ranitidine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (300 mg) + Pepto‐Bismol (bismuth salicylate)
Trial: 1889712
Drug: Ranitidine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (300 mg) + Roter (bismuth subnitrate)
Trial: 27173580
Drug: Ozone gas
RxNorm normalized name: ozone
DrugBank: Ozone (DB12510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ozone gas (32 g m-3)
Trial: 20144171
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol (50 microg)
Trial: 14616254
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (100 microg)
Trial: 3880523
Drug: Atropine (0.04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine (0.04 mg/kg i.v.)
Trial: 7733345
Drug: Propranolol (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (0.2 mg/kg i.v.)
Trial: 7214807
Drug: 6 g
RxNorm normalized name: FAPi-46 GA-68
DrugBank: FAPi-46 GA-68 (DB18827)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 g fractionated dose of iopanoic acid (Telepaque)
Trial: 26034931
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg of moxifloxacin per os once daily for 7 days
Trial: 26034931
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of metronidazole and 500 mg amoxicillin per os three times daily for 7 days
Trial: 12671775
Drug: Antiretroviral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiretroviral therapy provided at different study centers
Trial: 10993428
Drug: Pantoprazole (Pan)
DrugBank: Pantoprazole (DB00213)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pantoprazole (Pan) 80 mg O.D. for 1 week with clarithromycin (Cla) 500 mg B.I.D. and amoxicillin (Amo) 1 g B.I.D. for 5 days
Trial: 10993428
Drug: Omeprazole (Ome)
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole (Ome) 40 mg O.D. for 1 week with clarithromycin (Cla) 500 mg B.I.D. and amoxicillin (Amo) 1 g B.I.D. for 5 days
Trial: 22348910
Drug: Standard antifungal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antifungal treatment
Trial: 22348910
Drug: Standard antifungal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antifungal treatment plus pessary capsules containing 200 mg GMH (twice a week for thirty days)
Trial: 8777120
Drug: 0.25% bupivacaine
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 0.25% bupivacaine (25 mg)
Trial: 6668409
Drug: PGF2 alpha
RxNorm normalized name: Prostaglandin PGF2 alpha
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGF2 alpha gel 5 mg
Trial: 6668409
Drug: PGF2 alpha
RxNorm normalized name: Prostaglandin PGF2 alpha
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGF2 alpha gel 2.5 mg
Trial: 27521979
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 1200mg twice daily for eight weeks
Trial: 10407522
Drug: Ketamine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.5 mg/kg and midazolam 0.05 mg/kg (group I)
Trial: 10407522
Drug: Ketamine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.5 mg/kg and midazolam 0.1 mg/kg (group II)
Trial: 7380107
Drug: Diet regulation
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet regulation and 0.5 g tolbutamide t.i.d. (N = 49)
Trial: 7380107
Drug: Diet regulation
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet regulation and one placebo tablet t.i.d. (N = 48)
Trial: 19732495
Drug: Tinidazole 1
RxNorm normalized name: tinidazole 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tinidazole 1 g
Trial: 15142199
Drug: Rabeprazole (Proton-pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole (Proton-pump inhibitor) for 4 weeks
Trial: 10861309
Drug: N-acetylcysteine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (600 mg daily for 2 years)
Trial: 12126263
Drug: Enalapril 20
RxNorm normalized name: enalapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 20 mg o.d.
Trial: 12191747
Drug: Lisinopril 20
RxNorm normalized name: lisinopril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril 20 mg o.d.
Trial: 31913519
Drug: ubrogepant 100
RxNorm normalized name: ubrogepant 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ubrogepant 100 mg
Trial: 10639847
Drug: Ivermectin (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivermectin (6 mg)
Trial: 27153360
Drug: Fulranumab 1
RxNorm normalized name: Fulranumab
DrugBank: Fulranumab (DB12102)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fulranumab 1 mg (1 mgQ4 wk)
Trial: 27153360
Drug: Fulranumab 3
RxNorm normalized name: Fulranumab
DrugBank: Fulranumab (DB12102)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fulranumab 3 mg (3 mgQ4 wk)
Trial: 25826143
Drug: Pomegranate extract
RxNorm normalized name: Pomegranate Extract
DrugBank: Pomegranate (DB14317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pomegranate extract (1000 mg capsule, 7 days/week for 6 months)
Trial: 25826143
Drug: Placebo (noncaloric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (noncaloric capsule, 7 days/week for 6 months)
Trial: 19213793
Drug: UK-500,001 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UK-500,001 0.1 mg b.i.d.
Trial: 19213793
Drug: UK-500,001 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UK-500,001 0.4 mg b.i.d.
Trial: 17227996
Drug: Calcium supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplementation (1200 mg of elemental calcium daily for 4 years)
Trial: 11558856
Drug: Valsartan (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan (80 mg, once daily)
Trial: 9499281
Drug: Cefoxitin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoxitin (100 mg/kg/24 h)
Trial: 9499281
Drug: Ceftizoxime (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftizoxime (100 mg/kg/24 h)
Trial: 19239460
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of dutasteride and tamsulosin
Trial: 16432269
Drug: 10-mg rizatriptan
RxNorm normalized name: rizatriptan 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-mg rizatriptan orally disintegrating tablet with water (ODTc)
Trial: 16432269
Drug: 10-mg rizatriptan
RxNorm normalized name: rizatriptan 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-mg rizatriptan orally disintegrating tablet without water (ODTs)
Trial: 16432269
Drug: 10-mg rizatriptan
RxNorm normalized name: rizatriptan 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-mg rizatriptan tablet
Trial: 8703457
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl (F) 1 microgram/kg
Trial: 1393074
Drug: 1 ml
RxNorm normalized name: ethanol 1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 ml of 1% lignocaine at 20 degrees C
Trial: 27003829
Drug: Optimal doses
RxNorm normalized name: Optima Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal doses of renin-angiotensin system blockers (monotherapy or dual blockade)
Trial: 27003829
Drug: Renin-angiotensin system
RxNorm normalized name: Renin-angiotensin system inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Renin-angiotensin system blockers treatment
Trial: 16472283
Drug: moxifloxacin 400
RxNorm normalized name: moxifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: moxifloxacin 400 mg once daily for 7 days
Trial: 15290734
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g MaxEPA (omega-3 fish oils)
Trial: 15290734
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg copper
Trial: 11263764
Drug: Strength training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strength training (50-70% of repetition maximum, all major muscle groups, twice a week)
Trial: 3548440
Drug: Adenosine (5.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adenosine (5.1 mg/min)
Trial: 9146328
Drug: Duraflo II
RxNorm normalized name: Duraflor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duraflo II heparin-coated circuit (n = 10)
Trial: 9146328
Drug: Carmeda BioActive
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carmeda BioActive Surface heparin-coated circuit (n = 10)
Trial: 2885344
Drug: Buspirone 10
RxNorm normalized name: busPIRone 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone 10 to 30 mg daily
Trial: 2885344
Drug: Diazepam 10
RxNorm normalized name: diazepam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 10 to 30 mg daily
Trial: 21523338
Drug: Imatinib 400
RxNorm normalized name: imatinib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib 400 mg QD
Trial: 17936366
Drug: Fluoxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (20 mg daily for 90 days)
Trial: 29494855
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (conventional secondary preventive therapy for ischemic stroke)
Trial: 15234407
Drug: mibefradil 50
RxNorm normalized name: mibefradil 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mibefradil 50 mg
Trial: 15234407
Drug: mibefradil 100
RxNorm normalized name: mibefradil 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mibefradil 100 mg/day
Trial: 3144919
Drug: Subdermal estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subdermal estradiol pellets (25 mg, n = 10)
Trial: 21255977
Drug: Nutricia preOp
RxNorm normalized name: propylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutricia preOp (400 mL; 50.4 g carbohydrates; 260 mOsm/kg)
Trial: 21255977
Drug: Roosvicee Original
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roosvicee Original (400 mL; 48 g carbohydrates; 805 mOsm/kg)
Trial: 15499622
Drug: Dietary supplement
RxNorm normalized name: dietary supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary supplement (verum)
Trial: 9659026
Drug: 22 G
RxNorm normalized name: Empty Carpuject 2 mL 22 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 22 G cannula
Trial: 9659026
Drug: 20 G
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 G cannula
Trial: 2732892
Drug: Melatonin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (50 mg) administered at 7 pm
Trial: 2732892
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered at 9 am
Trial: 2732892
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered at 7 pm
Trial: 2732892
Drug: Melatonin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (50 mg) administered at both times
Trial: 30482192
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy (up to six individual sessions over 3 weeks)
Trial: 28486023
Drug: hemoglobin arm
RxNorm normalized name: HEMOGLOBIN
DrugBank: Hemoglobin (DB04945)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hemoglobin arm (maintaining hemoglobin between 85 and 100 g/L)
Trial: 17129496
Drug: SIT with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SIT with standardized house dust mite (HDM) vaccine
Trial: 16513246
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no hormone replacement therapy)
Trial: 29997294
Drug: Oral norovirus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral norovirus vaccine (single dose)
Trial: 25601335
Drug: Single fractions
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single fractions of 1.0 Gy applied two times a week, for a total dose of 6.0 Gy (total therapy time: 3 weeks)
Trial: 23928902
Drug: Flublok® (trivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flublok® (trivalent influenza vaccine)
Trial: 21037989
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Gram-stained smear, rapid urease test, and culture methods
Trial: 18218297
Drug: Moisture-resistant tablet
RxNorm normalized name: MOISTURIZER
DrugBank: Homosalate (DB11064)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Moisture-resistant tablet (dextran formulation)
Trial: 18218297
Drug: Standard tablet
RxNorm normalized name: Stangard
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard tablet (lactose formulation)
Trial: 9145877
Drug: Cefotaxime and
RxNorm normalized name: cefotaxime and beta-lactamase inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime and Ofloxacin combination therapy
Trial: 9145877
Drug: Ofloxacin monotherapy
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ofloxacin monotherapy
Trial: 9145877
Drug: Ofloxacin and
RxNorm normalized name: ofloxacin and ornidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin and Cefotaxime combination therapy
Trial: 7679532
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg of urapidil b.i.d. for 3 weeks (group L)
Trial: 7679532
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg b.i.d. for 1 week followed by 30 mg b.i.d. for 2 weeks (group M)
Trial: 7679532
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg b.i.d. for 1 week followed by 45 mg b.i.d. for 2 weeks (group H)
Trial: 3497380
Drug: Both vaccines
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both vaccines (Connaught and Praxis)
Trial: 23885519
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine 300 microg (group M, n=20)
Trial: 23885519
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine 300 microg + bupivacaine 2 mg (group MB, n=20)
Trial: 23885519
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine 300 microg + bupivacaine 2 mg + fentanyl 25 microg (group MBF, n=20)
Trial: 14583862
Drug: Dalbavancin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalbavancin (2 doses: 1100 mg IV once and 500 mg IV one week later)
Trial: 7722124
Drug: heparin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: heparin plus placebo
Trial: 7722124
Drug: rt‐PA (0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rt‐PA (0.03 mg/kg body weight per h for 3 consecutive days) plus heparin
Trial: 1974506
Drug: Carvedilol 25
RxNorm normalized name: carvedilol 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol 25 mg once daily (o.d.)
Trial: 1974506
Drug: Atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 50 mg once daily (o.d.)
Trial: 26880615
Drug: Indomethacin (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (1.2 mg/kg)
Trial: 26880615
Drug: Naproxen (4.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (4.2 mg/kg)
Trial: 16037180
Drug: 3 mL
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mL of saline IV
Trial: 9015519
Drug: Ivermectin, 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivermectin, 400 micrograms/kg, 12 fortnightly doses